KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy

American Journal of Pathology

Volumn 184, Issue 9, 2014, Pages 2430-2437

  Stein, Johannes ^a   Majores, Michael ^a   Rohde, Magdalena ^a   Lim, Soyoung ^c   Schneider, Simon ^a   Krappe, Eliana ^a   Ellinger, Jörg ^b   Dietel, Manfred ^d   Stephan, Carsten ^d   Jung, Klaus ^d   Perner, Sven ^a   Kristiansen, Glen ^a   Kirfel, Jutta ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; KDM5C PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; KDM5C PROTEIN, HUMAN; N DEMETHYLASE; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FOLLOW UP; GENE OVEREXPRESSION; GENE SILENCING; GENETIC MARKER; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CARCINOMA; RADICAL RETROPUBIC PROSTATECTOMY; RECURRENCE FREE SURVIVAL; BIOSYNTHESIS; BLOOD; DISEASE FREE SURVIVAL; GENETIC TRANSFECTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATECTOMY; PROSTATIC NEOPLASMS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXIDOREDUCTASES, N-DEMETHYLATING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TISSUE ARRAY ANALYSIS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84906222616     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.05.022     Document Type: Article

References (28)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. A. Dal Pra, F.L. Cury, and L. Souhami Radiation therapy and androgen deprivation in the management of high risk prostate cancer Int Braz J Urol 37 2011 161 175 discussion 176-179
3. C. Pezaro, and G. Attard Prostate cancer in 2011: redefining the therapeutic landscape for CRPC Nat Rev Urol 9 2012 63 64
4. F. Saad, and S.J. Hotte Guidelines for the management of castrate-resistant prostate cancer Can Urol Assoc J 4 2010 380 384
5. G. Attard, and J.S. de Bono Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients Clin Cancer Res 17 2011 3867 3875
6. Y. Shi, F. Lan, C. Matson, P. Mulligan, J.R. Whetstine, P.A. Cole, R.A. Casero, and Y. Shi Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
7. E. Metzger, M. Wissmann, N. Yin, J.M. Müller, R. Schneider, A.H. Peters, T. Günther, R. Buettner, and R. Schüle LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 437 2005 436 439
8. E. Metzger, A. Imhof, D. Patel, P. Kahl, K. Hoffmeyer, N. Friedrichs, J.M. Müller, H. Greschik, J. Kirfel, S. Ji, N. Kunowska, C. Beisenherz-Huss, T. Günther, R. Buettner, and R. Schüle Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4 Nature 464 2010 792 796
9. Y. Tsukada, J. Fang, H. Erdjument-Bromage, M.E. Warren, C.H. Borchers, P. Tempst, and Y. Zhang Histone demethylation by a family of JmjC domain-containing proteins Nature 439 2006 811 816
10. W. Lin, J. Cao, J. Liu, M.L. Beshiri, Y. Fujiwara, J. Francis, A.D. Cherniack, C. Geisen, L.P. Blair, M.R. Zou, X. Shen, D. Kawamori, Z. Liu, C. Grisanzio, H. Watanabe, Y.A. Minamishima, Q. Zhang, R.N. Kulkarni, S. Signoretti, S.J. Rodig, R.T. Bronson, S.H. Orkin, D.P. Tuck, E.V. Benevolenskaya, M. Meyerson, W.G. Kaelin Jr., and Q. Yan Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1 Proc Natl Acad Sci U S A 108 2011 13379 13386
11. L.P. Blair, J. Cao, M.R. Zou, J. Sayegh, and Q. Yan Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer Cancers 3 2011 1383 1404
12. R.A. Varier, N.S. Outchkourov, P. de Graaf, F.M. van Schaik, H.J. Ensing, F. Wang, J.M. Higgins, G.J. Kops, and H.T. Timmers A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes EMBO J 29 2010 3967 3978
13. A. Roesch, M. Fukunaga-Kalabis, E.C. Schmidt, S.E. Zabierowski, P.A. Brafford, A. Vultur, D. Basu, P. Gimotty, T. Vogt, and M. Herlyn A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth Cell 141 2010 583 594
14. S.V. Sharma, D.Y. Lee, B. Li, M.P. Quinlan, F. Takahashi, S. Maheswaran, U. McDermott, N. Azizian, L. Zou, M.A. Fischbach, K.K. Wong, K. Brandstetter, B. Wittner, S. Ramaswamy, M. Classon, and J. Settleman A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 2010 69 80
15. S. Iwase, F. Lan, P. Bayliss, L. de la Torre-Ubieta, M. Huarte, H.H. Qi, J.R. Whetstine, A. Bonni, T.M. Roberts, and Y. Shi The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases Cell 128 2007 1077 1088
16. G.L. Dalgliesh, K. Furge, C. Greenman, L. Chen, G. Bignell, and A. Butler et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
17. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, L.L. Egevad ISUP Grading Committee The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
18. Z. Liang, M. Diamond, J.A. Smith, M. Schnell, and R. Daniel Proliferating cell nuclear antigen is required for loading of the SMCX/KMD5C histone demethylase onto chromatin Epigenetics Chromatin 4 2011 18
19. S. Lim, A. Janzer, A. Becker, A. Zimmer, R. Schüle, R. Buettner, and J. Kirfel Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Carcinogenesis 31 2010 512 520
20. G. Kristiansen, M. Stöckle, P. Albers, H. Schmidberger, P. Martus, S. Wellek, M. Härter, R. Bussar-Maatz, and T. Wiegel [The importance of pathology in the German prostate cancer study PREFERE] German Pathologe 34 2013 449 462
21. Y. Xiang, Z. Zhu, G. Han, X. Ye, B. Xu, Z. Peng, Y. Ma, Y. Yu, H. Lin, A.P. Chen, and C.D. Chen JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Proc Natl Acad Sci U S A 104 2007 19226 19231
22. T. Abbas, and A. Dutta p21 in cancer: intricate networks and multiple activities Nat Rev Cancer 9 2009 400 414
23. T.D. Kim, S. Shin, and R. Janknecht Repression of Smad3 activity by histone demethylase SMCX/JARID1C Biochem Biophys Res Commun 366 2008 563 567
24. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, P. ten Dijke, and G. van der Pluijm TGF-beta and BMP7 interactions in tumour progression and bone metastasis Clin Exp Metastasis 24 2007 609 617
25. R.J. Klose, Q. Yan, Z. Tothova, K. Yamane, H. Erdjument-Bromage, P. Tempst, D.G. Gilliland, Y. Zhang, and W.G. Kaelin Jr. The retinoblastoma binding protein RBP2 is an H3K4 demethylase Cell 128 2007 889 900
26. A. Barrett, S. Santangelo, K. Tan, S. Catchpole, K. Roberts, B. Spencer-Dene, D. Hall, A. Scibetta, J. Burchell, E. Verdin, P. Freemont, and J. Taylor-Papadimitriou Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases Int J Cancer 121 2007 265 275
27. P.H. Huang, C.H. Chen, C.C. Chou, A.M. Sargeant, S.K. Kulp, C.M. Teng, J.C. Byrd, and C.S. Chen Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases Mol Pharmacol 79 2011 197 206
28. L. Wang, J. Chang, D. Varghese, M. Dellinger, S. Kumar, A.M. Best, J. Ruiz, R. Bruick, S. Peña-Llopis, J. Xu, D.J. Babinski, D.E. Frantz, R.A. Brekken, A.M. Quinn, A. Simeonov, J. Easmon, and E.D. Martinez A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth Nat Commun 4 2013 2035